Revenue
2022
2023
2024
2025
Axsome Therapeutics, Inc. (AXSM)
Price$209.95Cached quote
Net income
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $638.5M | $385.7M | $270.6M | $50.0M | — | — | — | — | — | — | — | — |
| Gross profit | $591.0M | $352.4M | $244.5M | $44.8M | — | — | — | — | — | — | — | — |
| Gross margin | 92.56% | 91.37% | 90.37% | 89.61% | — | — | — | — | — | — | — | — |
| Research & development | $183.3M | $187.1M | $97.9M | $57.9M | $58.1M | $70.2M | $53.6M | $23.5M | $20.0M | $21.2M | $6.8M | $4.3M |
| Operating expenses | $805.3M | $666.3M | $502.4M | $229.8M | $124.7M | $99.1M | $67.2M | $32.8M | $27.2M | $27.5M | $9.2M | $5.7M |
| Operating income | −$166.8M | −$280.6M | −$231.8M | −$179.8M | −$124.7M | −$99.1M | −$67.2M | −$32.8M | −$27.2M | −$27.5M | −$9.2M | −$5.7M |
| Operating margin | −26.12% | −72.74% | −85.67% | −359.33% | — | — | — | — | — | — | — | — |
| EBITDA | −$159.9M | −$273.6M | −$225.0M | −$175.4M | −$124.6M | −$99.1M | −$67.2M | −$32.8M | −$27.1M | −$27.5M | −$9.2M | — |
| EBITDA margin | −25.04% | −70.95% | −83.15% | −350.53% | — | — | — | — | — | — | — | — |
| Net income | −$183.2M | −$287.2M | −$239.2M | −$187.1M | −$130.4M | −$102.9M | −$68.3M | −$31.0M | −$28.9M | −$27.2M | −$12.2M | −$6.0M |
| Net profit margin | −28.69% | −74.47% | −88.41% | −373.99% | — | — | — | — | — | — | — | — |
| Basic EPSper basic share | -$3.68 | -$5.99 | -$5.27 | -$4.60 | -$3.47 | -$2.77 | -$2.01 | -$1.15 | -$1.27 | -$1.42 | -$1.02 | -$0.66 |
| Diluted EPSper diluted share | -$3.68 | -$5.99 | -$5.27 | -$4.60 | -$3.47 | -$2.77 | -$2.01 | -$1.15 | -$1.27 | -$1.42 | -$1.02 | -$0.66 |
Owners
Reported shareholders
5.93%of listed shares
BlackRock, Inc.3.1M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | 5.93%3.1M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | 3.79%1.98M shares |
VANGUARD CAPITAL MANAGEMENT LLC | 3.76%1.97M shares |
Invesco Ltd. | 3.20%1.67M shares |
FMR LLC | 2.94%1.54M shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.85%967.17K shares |
Assenagon Asset Management S.A. | 1.74%909.36K shares |
MORGAN STANLEY | 1.54%804.08K shares |
STATE STREET CORP | 1.50%785.66K shares |
Deep Track Capital, LP | 1.34%700K shares |
TWO SIGMA INVESTMENTS, LP | 1.28%669.48K shares |
FRANKLIN RESOURCES INC | 1.28%668.37K shares |
WELLINGTON MANAGEMENT GROUP LLP | 1.25%653.92K shares |
ALETHEA CAPITAL MANAGEMENT, LLC | 1.24%648.76K shares |
PRICE T ROWE ASSOCIATES INC /MD/ | 1.23%642.89K shares |
D. E. Shaw & Co., Inc. | 1.16%604.75K shares |
MILLENNIUM MANAGEMENT LLC | 1.06%556.09K shares |
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.03%539.41K shares |
NORGES BANK | 0.98%514.27K shares |
FIRST TRUST ADVISORS LP | 0.92%482.06K shares |
Percentages use 52.3M shares of this listed class outstanding on Jun 30, 2026.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 11, 2026Form 4 · 10b5-1 | JEFFS ROGERDirector | SellCommon Stock | 286 | $249.12 | $71.2K | 58.4K |
| Jun 10, 2026Form 4 · 10b5-1 | JEFFS ROGERDirector | SellCommon Stock | 286 | $246.18 | $70.4K | 58.7K |
| Jun 10, 2026Form 4 · 10b5-1 | Mahony SusanDirector | SellCommon Stock | 300 | $246.18 | $73.9K | 829 |
| Jun 10, 2026Form 4 · 10b5-1 | Coleman MarkDirector | SellCommon Stock | 643 | $249.00 | $160.1K | 30.4K |
| Jun 9, 2026Form 4 · 10b5-1 | Mahony SusanDirector | SellCommon Stock | 300 | $237.21 | $71.2K | 1.1K |